Mechanisms of Action of New Mood-Stabilizing Drugs

Joseph Levine; Yuly Bersudsky; Carmit Nadri; Yuri Yaroslavsky; Abed Azab; Alex Mishori; Galila Agam; Robert H. Belmaker

doi:10.3109/9780203912485-57

Mechanisms of Action of New Mood-Stabilizing Drugs

Joseph Levine
, Yuly Bersudsky
, Carmit Nadri
, Yuri Yaroslavsky
, Abed Azab
, Alex Mishori
, Galila Agam
, Robert H. Belmaker

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

7 Scopus citations

Abstract

Oxcarbazepine, 10-keto analog of carbamazepine, is indicated for the treatment of partial seizures with and without secondary generalization. There are data on the use of oxcarbazepine in patients with bipolar, schizoaffective, and schizophrenia-related disorders [13]. Macdonald and Kelly [14] suggested that its similarity in structure and clinical efﬁcacy to carbamazepine suggests that its mechanism of action is similar to that of carbamazepine.

Original language	English
Title of host publication	Handbook of Medical Psychiatry
Publisher	Taylor and Francis
Pages	793-806
Number of pages	14
ISBN (Electronic)	9780203912485
ISBN (Print)	9780824708351
DOIs	https://doi.org/10.3109/9780203912485-57
State	Published - 1 Jan 2003

ASJC Scopus subject areas

General Medicine

Access to Document

10.3109/9780203912485-57

Cite this

@inbook{2abae66d3dec4f6e91ae8738eeabd0ca,

title = "Mechanisms of Action of New Mood-Stabilizing Drugs",

abstract = "Oxcarbazepine, 10-keto analog of carbamazepine, is indicated for the treatment of partial seizures with and without secondary generalization. There are data on the use of oxcarbazepine in patients with bipolar, schizoaffective, and schizophrenia-related disorders [13]. Macdonald and Kelly [14] suggested that its similarity in structure and clinical efﬁcacy to carbamazepine suggests that its mechanism of action is similar to that of carbamazepine.",

author = "Joseph Levine and Yuly Bersudsky and Carmit Nadri and Yuri Yaroslavsky and Abed Azab and Alex Mishori and Galila Agam and Belmaker, \{Robert H.\}",

note = "Publisher Copyright: {\textcopyright} 2003 by Taylor and Francis Group, LLC.",

year = "2003",

month = jan,

day = "1",

doi = "10.3109/9780203912485-57",

language = "English",

isbn = "9780824708351",

pages = "793--806",

booktitle = "Handbook of Medical Psychiatry",

publisher = "Taylor and Francis",

}

TY - CHAP

T1 - Mechanisms of Action of New Mood-Stabilizing Drugs

AU - Levine, Joseph

AU - Bersudsky, Yuly

AU - Nadri, Carmit

AU - Yaroslavsky, Yuri

AU - Azab, Abed

AU - Mishori, Alex

AU - Agam, Galila

AU - Belmaker, Robert H.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Oxcarbazepine, 10-keto analog of carbamazepine, is indicated for the treatment of partial seizures with and without secondary generalization. There are data on the use of oxcarbazepine in patients with bipolar, schizoaffective, and schizophrenia-related disorders [13]. Macdonald and Kelly [14] suggested that its similarity in structure and clinical efﬁcacy to carbamazepine suggests that its mechanism of action is similar to that of carbamazepine.

AB - Oxcarbazepine, 10-keto analog of carbamazepine, is indicated for the treatment of partial seizures with and without secondary generalization. There are data on the use of oxcarbazepine in patients with bipolar, schizoaffective, and schizophrenia-related disorders [13]. Macdonald and Kelly [14] suggested that its similarity in structure and clinical efﬁcacy to carbamazepine suggests that its mechanism of action is similar to that of carbamazepine.

UR - https://www.scopus.com/pages/publications/0141492362

U2 - 10.3109/9780203912485-57

DO - 10.3109/9780203912485-57

M3 - Chapter

AN - SCOPUS:0141492362

SN - 9780824708351

SP - 793

EP - 806

BT - Handbook of Medical Psychiatry

PB - Taylor and Francis

ER -

Mechanisms of Action of New Mood-Stabilizing Drugs

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this